Listed

Bone Biologics Corp

BBLGNasdaqCIK 1419554HealthcareFiscal year ends Dec 31

Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Bone Biologics Corp, Reports and events
FiledFormWhat it isAccession number
2023-11-2007:46 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-041982
2023-11-2007:00 ETDEF 14AProxy statementPeriod 2023-11-200001493152-23-041973
2023-11-2006:50 ET10-K/AAnnual report, amendedPeriod 2022-12-310001493152-23-041971
2023-11-1416:05 ET10-QQuarterly reportPeriod 2023-09-300001493152-23-041059
2023-10-2406:06 ET8-K5.03 Amendment to articles or bylaws0001493152-23-038029
2023-09-2917:19 ET8-K3.01 Delisting notice0001493152-23-034907
2023-09-1216:01 ET8-K5.07 Shareholder vote results0001493152-23-032347
2023-08-1415:17 ET10-QQuarterly reportPeriod 2023-06-300001493152-23-028330
2023-08-0306:15 ETDEF 14AProxy statementPeriod 2023-08-030001493152-23-026502
2023-07-0516:41 ET8-K8.01 Other events0001493152-23-023458
2023-06-1614:53 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-021605
2023-06-1306:04 ETS-1/ARegistration statement, amended0001493152-23-020997
2023-06-0617:19 ETS-1/ARegistration statement, amended0001493152-23-020316
2023-06-0613:14 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-23-020241
2023-05-1916:35 ET8-K3.01 Delisting notice0001493152-23-018373
2023-05-1516:18 ET10-QQuarterly reportPeriod 2023-03-310001493152-23-017393
2023-05-0117:24 ETS-1Registration statement0001493152-23-015035
2023-03-3016:51 ET10-KAnnual reportPeriod 2022-12-310001493152-23-009799
2023-03-2916:57 ETSC 13D/AOwnership report, active investor, amended0001493152-23-009501
2022-12-2116:54 ET8-K5.02 Departure or appointment of officers or directors0001493152-22-036161
2022-11-2116:29 ET8-K3.01 Delisting notice0001493152-22-033115
2022-11-1406:32 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-031540
2022-10-2509:49 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-029492
2022-10-1306:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-028300
2022-10-1116:59 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-028136
2022-10-0518:17 ETS-1/ARegistration statement, amended0001493152-22-027628
2022-10-0406:16 ETS-1/ARegistration statement, amended0001493152-22-027481
2022-09-2316:58 ETS-1Registration statement0001493152-22-026702
2022-08-2420:23 ET8-K5.07 Shareholder vote results0001493152-22-023895
2022-08-1111:44 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-021997
2022-07-0611:18 ETDEF 14AProxy statementPeriod 2022-07-060001493152-22-018642
2022-06-0917:05 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-22-016325
2022-05-2311:16 ET8-K5.08 Item not in the standard list0001493152-22-014716
2022-05-1311:49 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013230
2022-03-1515:19 ET10-KAnnual reportPeriod 2021-12-310001493152-22-006850
2022-03-0806:06 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-006230
2021-12-2213:51 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-21-032259
2021-11-1512:38 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-028429
2021-11-0106:06 ETSC 13D/AOwnership report, active investor, amended0001493152-21-026809
2021-10-1916:32 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-025784
2021-10-1506:05 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-025492
2021-10-0717:31 ETS-1/ARegistration statement, amended0001493152-21-024979
2021-10-0617:16 ETS-1/ARegistration statement, amended0001493152-21-024833
2021-08-3016:36 ETS-1/ARegistration statement, amended0001493152-21-021565
2021-08-1613:16 ET10-QQuarterly reportPeriod 2021-06-300001493152-21-020020
2021-06-2817:19 ETS-1Registration statement0001493152-21-015404
2021-06-0715:14 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-21-013724
2021-05-2115:19 ET10-QQuarterly reportPeriod 2021-03-310001493152-21-012491
2021-04-1516:31 ET10-KAnnual reportPeriod 2020-12-310001493152-21-008887
2021-04-1516:22 ET10-QQuarterly reportPeriod 2020-09-300001493152-21-008878

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:46 ET. Listed shows no prices and gives no investment advice.